Načítá se...
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Cellular therapies with CD4+ T regulatory cells (Tregs) hold promise of efficacious treatment for the variety of autoimmune and allergic diseases as well as posttransplant complications. Nevertheless, current manufacturing of Tregs as a cellular medicinal product varies between different laboratorie...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Frontiers Media S.A.
2018-01-01
|
Edice: | Frontiers in Immunology |
Témata: | |
On-line přístup: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01844/full |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|